Ruiwen He defended his thesis on 24 November 2022, at ISA in Lille. The purpose of his thesis was to…
GD Biotech is a spin-off of the Gènes Diffusion group, a leading European player in animal genetics and reproduction.
GD Biotech draws upon the skills of a multidisciplinary team (50% biotechnicians and 50% bioinformaticians), and has a portfolio of biotechnologies and bioinformatics tools.
Because the observable traits of living organisms are the result of genetic potential in a given context, our solutions cover DNA analysis (genotyping), biomarker detection (multiplex-ELISA) and environmental characterization (microbiota).
GD Biotech operates in the agricultural, food and environmental sectors. Our analysis and interpretation solutions are tailored to meet the needs of our customers. Through this “custom” intervention, we facilitate and accelerate the concrete use of your biological data.
Tools developed for concrete problems, tested for our own needs, comprehensive expertise from the collection of biological samples to the exploitation of analyses, human support close to your needs.
A 100% exclusive know-how
The multiplexed ELISA is a GD Biotech exclusive, for quality control, pathogen detection, or phenotype collection applications in fields as varied as food processing, ecology and agriculture.
High Definition Technology
Multiplex-ELISA is based on the principle of ELISA tests, but parallelized for the simultaneous detection of dozens of biomarkers per analysis. This approach is made possible by the miniaturization of a probe array at the bottom of each well. Parallelization enables faster analysis throughputs and reduced labor, cost and sample consumption without compromising test performance.
This technology has been used to monitor the immune response of pigs infected with different strains of porcine Coronavirus (Malbec et al., 2020). At the heart of the Covid-19 pandemic, our teams actively participated in the adaptation of the porcine coronavirus test for the development of the CoViDiag serological test, produced and commercialized by our partner Innobiochips. Today, this diagnostic test is routinely used by analytical laboratories (Laboratoires Biopath) and research teams to monitor the immune response to Covid-19 (Brochot et al., 2021).
As a genotyping major player in France, GD Biotech has a technical platform dedicated to the production and exploitation of routine high-throughput genotyping data. This platform uses the DNA chip technology developed by Illumina.
The quality of the data produced is recognized by the ISAG (International Society for Animal Genetics), and the platform systematically ranks highest after each inter-laboratory comparison (genotyping accuracy > 98%).
We distinguish ourselves by our ability to adapt to your constraints (biological matrix, deadline, etc.), unlike most service providers in this market. Our expertise is notably linked to the daily use of this technology as a support for genomic indexing of cattle for the partners of the Gènes Diffusion group.
GD Biotech bénéficie de l'agrément “Crédit Impôt Recherche", mesure du soutien aux activités de recherches et développement (R&D) des entreprises.